Skip to main content
AI Market Summary
Loading market intelligence...

Constellation Pharmaceuticals Inc (CNST) Stock Forecast 2025 - AI Price Prediction & Analysis


Constellation Pharmaceuticals Inc (CNST) AI Stock Price Forecast & Investment Analysis

Constellation Pharmaceuticals Inc Stock Price Chart and Technical Analysis

Loading Constellation Pharmaceuticals Inc interactive price chart and technical analysis...

Constellation Pharmaceuticals Inc (CNST) - Comprehensive Stock Analysis & Investment Research

Deep dive into Constellation Pharmaceuticals Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Constellation Pharmaceuticals Inc, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Constellation Pharmaceuticals Inc: Constellation Pharmaceuticals Inc operates in the Professional, Scientific, and Technical Services sector, making it an emerging small-cap investment.

Constellation Pharmaceuticals Inc (Stock Symbol: CNST) is a leading company in the Professional, Scientific, and Technical Services sector , specifically operating within the Research and Development in Biotechnology industry.

The organization employs approximately 106 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Constellation Pharmaceuticals Inc's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Constellation Pharmaceuticals Inc:

Market Capitalization: $1564 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -40.7% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Constellation Pharmaceuticals Inc stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Constellation Pharmaceuticals Inc: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Constellation Pharmaceuticals Inc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Constellation Pharmaceuticals Inc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Constellation Pharmaceuticals Inc: Market positioning analysis based on available financial and operational metrics.

Constellation Pharmaceuticals Inc strategically competes in the highly dynamic Research and Development in Biotechnology marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

Constellation Pharmaceuticals Inc (CNST) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Constellation Pharmaceuticals Inc stock analysis.

Loading Constellation Pharmaceuticals Inc comprehensive fundamental analysis and insider trading data...

Deep dive into Constellation Pharmaceuticals Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Constellation Pharmaceuticals Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Constellation Pharmaceuticals Inc: With a P/E ratio of -11.18, the market sees the stock as potentially undervalued.

P/E Ratio -11.18x
P/B Ratio 4.32x
Market Cap $1564M
EPS $-3.04
Book Value/Share $7.87
FCF/Share $-2.29
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Constellation Pharmaceuticals Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Constellation Pharmaceuticals Inc: An ROE of -40.7% indicates room for improvement in shareholder value creation.

ROE -40.7%
ROA -36.4%
ROIC -38.2%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Constellation Pharmaceuticals Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Constellation Pharmaceuticals Inc: A current ratio of 15.39 indicates strong liquidity.

Current Ratio 15.39x
Quick Ratio 15.08x
D/E Ratio 0.11x
Financial Leverage 1.07x
Interest Coverage -69.1x
Working Capital $398M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Constellation Pharmaceuticals Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Constellation Pharmaceuticals Inc: Free cash flow of $-127M indicates cash challenges that need attention.

Operating Cash Flow $-125M
Free Cash Flow $-127M
Capital Spending $-1M
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Constellation Pharmaceuticals Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Constellation Pharmaceuticals Inc:

Understanding Financial Statement Data

What these metrics mean: Key figures from Constellation Pharmaceuticals Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Constellation Pharmaceuticals Inc:

Income Statement ($ Millions)
Operating Income $-139M
Net Income $-141M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 97%
Cash & Short-term Investments 95%
Total Liabilities 6%
Short-term Debt 21%
Dividend & Shareholder Information
Shares Outstanding 46M

Latest Constellation Pharmaceuticals Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Constellation Pharmaceuticals Inc (CNST) stock price and investment outlook.

, source: Benzinga.com

Past Insider Trading and Trends Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data ...

, source: The Business Journals

Constellation Pharmaceuticals Inc. has announced a partnership with The Leukemia & Lymphoma Society worth up to $7.5 million to support Phase 1 trials of the Cambridge biopharmaceutical ...

, source: Benzinga.com

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to ...

, source: MarketWatch

Visit a quote page and your recently viewed tickers will be displayed here. Richard S. Levy currently works at Gliknik, Inc., as Non-Executive Director from 2014, Kiniksa Pharmaceuticals Ltd., as ...

Constellation Pharmaceuticals Inc Competitors & Peer Analysis - Professional, Scientific, and Technical Services Sector

Comparative analysis of Constellation Pharmaceuticals Inc against industry peers and competitors in the Professional, Scientific, and Technical Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - Constellation Pharmaceuticals Inc Stock Forecast

How accurate are Constellation Pharmaceuticals Inc stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for CNST predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Constellation Pharmaceuticals Inc stock price forecasts?

Our analysis considers Constellation Pharmaceuticals Inc's financial metrics, Professional, Scientific, and Technical Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Constellation Pharmaceuticals Inc a good investment in 2025?

Based on our AI analysis, Constellation Pharmaceuticals Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Constellation Pharmaceuticals Inc forecasts updated?

Constellation Pharmaceuticals Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Constellation Pharmaceuticals Inc Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Constellation Pharmaceuticals Inc stock.

My Portfolio

Investment Dashboard

Loading your portfolio...